Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

DOW vs LYB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

DOW Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 5–5 Matrix Metrics)

DOW Overall Winner 6-Pillar Tally: DOW 3 – 3 LYB Matrix Metrics: DOW 5 – 5 LYB

As of Nov 20, 2026, Dow Inc. (DOW) is the stronger overall head-to-head candidate over LyondellBasell Industries N.V. Class A (LYB) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Options & Positioning, R&D & Supply-Chain Moat). DOW carries a Unified Composite Score of 48.6/100 (HOLD) at $29.03 (15.9x Forward P/E, 4.3% operating margin), whereas LYB carries 38.6/100 (SELL) at $55.84 (8.8x Forward P/E, 9.2% operating margin).

  • Technical & Structure Timing Caution: DOW trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 36.1); meanwhile LYB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DOW vs LYB
DOW NYSE Head-to-Head Winner
Dow Inc.
Plastic Materials, Synth Resins & Nonvulcan Elastomers
$29.03
-4.03% 1D
Market Cap $21.9B
TTM Revenue $42.6B
Forward P/E 15.9x
Beta / 30D Vol -0.52β · 37% Vol
Unified Composite Score
48.6 / 100 HOLD
Tech 39.0 Fund 54.0 Flow 57.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 36
RSI-14: 36.1 · SMA20: $32.42 · SMA50: $30.36
LYB NYSE
LyondellBasell Industries N.V. Class A
Industrial Organic Chemicals
$55.84
-4.04% 1D
Market Cap $18.8B
TTM Revenue $32.0B
Forward P/E 8.8x
Beta / 30D Vol -0.71β · 39% Vol
Unified Composite Score
38.6 / 100 SELL
Tech 39.0 Fund 52.0 Flow 57.0 Mom 56.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 33
RSI-14: 33.1 · SMA20: $63.00 · SMA50: $61.89

6-Pillar Scorecard Institutional Category Breakdown (DOW 3 – 3 LYB)

Columns: Metric · DOW · LYB
1. Valuation Multiples LYB
Forward P/E 15.9x 8.8x
Trailing P/E 16.2x 14.1x
PEG Ratio 0.54x 0.85x
EV / Revenue 0.9x 0.9x
2. Growth & Scale DOW
Revenue Growth (YoY) +13.0% +10.0%
Earnings Growth (YoY) +675.0% +396.0%
TTM Revenue (USD) $42.6B $32.0B
Market Cap $21.9B $18.8B
3. Profitability & Quality LYB
Gross Margin 11.0% 14.6%
Operating Margin 4.3% 9.2%
Net Profit Margin -2.1% 4.0%
Return on Equity (ROE) -3.2% 12.2%
4. Balance Sheet & Cash Flow LYB
Cash Generation (TTM) $2.17B $2.41B
Cash Flow Margin 5.1% 7.6%
Net Cash / Leverage $14.8B Net Debt (1.17x D/E) $10.3B Net Debt (1.21x D/E)
Dividend Yield 4.61% 5.88%
5. Options & Positioning DOW
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 40.2% (20th %ile) 39.2% (38th %ile)
Put/Call OI Skew 0.76x (Call-Skewed) 1.34x (Put-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat DOW
OpEx & R&D Intensity 6.7% of Rev ($2.86B) 5.4% of Rev ($1.73B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Chemicals Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DOW (5) vs LYB (5)
Institutional Metric DOW LYB Criterion Row Edge
Market Capitalization
Scale
$21.9B $18.8B Larger Scale DOW
Trailing P/E Ratio
Valuation
16.2x 14.1x Lower Multiple LYB
Forward P/E Ratio
Valuation
15.9x 8.8x Lower Multiple LYB
Revenue Growth (YoY)
Growth
+13.0% +10.0% Higher Growth DOW
Operating Margin (TTM)
Profitability
4.3% 9.2% Higher Margin LYB
Net Profit Margin
Profitability
-2.1% 4.0% Higher Margin LYB
Return on Equity (ROE)
Capital Efficiency
-3.2% 12.2% Higher ROE LYB
52-Week Range Position
Momentum
37% ($21–$43) 33% ($42–$84) Stronger Trend DOW
Beta / 30D Volatility
Risk Regime
-0.52β · 37% Vol -0.71β · 39% Vol Lower Realized Risk DOW
Unified Institutional Score
Composite Signal
48.6 / 100 (HOLD) 38.6 / 100 (SELL) Higher Composite DOW
Trailing 12M Revenue (USD)
Operating Scale
$42.6B $32.0B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
11.0% 14.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.54x PEG · 0.9x EV/Rev 0.85x PEG · 0.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$2.17B ($14.8B Net Debt (1.17x D/E)) $2.41B ($10.3B Net Debt (1.21x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DOW +5.84 pp
DOW: -8.74% · LYB: -14.58%
3M Horizon DOW +6.69 pp
DOW: -7.67% · LYB: -14.36%
6M Horizon DOW +0.53 pp
DOW: -19.38% · LYB: -19.91%
1Y Horizon DOW +5.64 pp
DOW: +36.23% · LYB: +30.59%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period DOW Revenue LYB Revenue DOW Op. Margin LYB Op. Margin Margin Leader
FY2018 $49.6B $38.1B N/A 13.7% LYB
FY2019 $43.0B $33.9B N/A 12.1% LYB
FY2020 $38.5B $27.0B N/A 5.8% LYB
FY2021 $55.0B $46.2B N/A 14.7% LYB
FY2022 $56.9B $50.5B N/A 10.1% LYB
FY2023 $44.6B $33.3B N/A 8.2% LYB
FY2024 $43.0B $33.4B N/A 5.7% LYB
FY2025 $40.0B $30.1B N/A -1.4% LYB

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DOW CONSOLIDATION
15d in phase · OBV DISTRIBUTION
Current IV 40.2%
IV Percentile 20th %ile
Put/Call OI Skew 0.76x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact DOW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LYB CONSOLIDATION
65d in phase · OBV DISTRIBUTION
Current IV 39.2%
IV Percentile 38th %ile
Put/Call OI Skew 1.34x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact LYB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $31.96 · IV 37.8%

DOW vs. LYB: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of DOW ($3,196) vs. LYB ($6,167) against risk-defined 5-day vertical and put-wall option structures.

DOW Spot $31.96 · IV 37.8%
DOW Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $32.5 / $35 Bull Call Spread

Buy 1x $32.5C · Sell 1x $35C · 31d

Net Entry $73 Debit
T+5d @ +5% Move +$44 (+60%)
Max Risk / Buffer $73 Capped
5d Edge & Liquidity 1.0x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $30 / $27.5 Bull Put Spread

Sell 1x $30P · Buy 1x $27.5P · 31d

Net Entry $51 Credit
Max Credit / Yield +$51 (+25.6% RoM)
Max Risk / Buffer -7.7% Cushion ($199 Mgn)
5d Edge & Liquidity 73% PoP · Liq A
Simulate 5-Day Payoff →
LYB Spot $61.67 · IV 38.0%
LYB Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $60 / $65 Bull Call Spread

Buy 1x $60C · Sell 1x $65C · 31d

Net Entry $235 Debit
T+5d @ +5% Move +$89 (+38%)
Max Risk / Buffer $235 Capped
5d Edge & Liquidity 0.8x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $57.5 / $55 Bull Put Spread

Sell 1x $57.5P · Buy 1x $55P · 31d

Net Entry $56 Credit
Max Credit / Yield +$56 (+28.9% RoM)
Max Risk / Buffer -7.7% Cushion ($194 Mgn)
5d Edge & Liquidity 74% PoP · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DOW Moat Profile Cyclical / Execution-Driven Positioning
Chemicals Operator
Competes within the Chemicals value chain with $21.9B market capitalization and 4.3% operating margin.
OpEx & R&D Reinvestment 6.7% of Rev ($2.86B)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (16 partners):
Exxon Mobil Corporation Chevron Corporation Saudi Arabian Oil Company China Petroleum & Chemical Corporation
LYB Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $18.8B market capitalization and 9.2% operating margin.
OpEx & R&D Reinvestment 5.4% of Rev ($1.73B)
90D Engineering Disclosures 0 Published

Investor FAQ DOW vs LYB Key Questions & Quantitative Answers

As of Nov 20, 2026, Dow Inc. (DOW) is the stronger overall head-to-head candidate over LyondellBasell Industries N.V. Class A (LYB) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Options & Positioning, R&D & Supply-Chain Moat). DOW carries a Unified Composite Score of 48.6/100 (HOLD) at $29.03 (15.9x Forward P/E, 4.3% operating margin), whereas LYB carries 38.6/100 (SELL) at $55.84 (8.8x Forward P/E, 9.2% operating margin). Technical & Structure Timing Caution: DOW trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 36.1); meanwhile LYB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

DOW leads the Growth & Scale pillar: DOW posts +13.0% YoY revenue growth and +675.0% YoY earnings growth on $42.6B TTM revenue (11.0% gross margin, 4.3% operating margin), compared with LYB at +10.0% YoY revenue growth and +396.0% YoY earnings growth on $32.0B TTM revenue (14.6% gross margin, 9.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), DOW cumulative revenue shifted -19.4% while LYB shifted -20.9%. In operating R&D and SG&A reinvestment, DOW deploys 6.7% of Rev ($2.86B) (0 90-day corporate R&D disclosures) versus 5.4% of Rev ($1.73B) (0 disclosures) for LYB.

LYB screens cheaper on headline valuation multiples. DOW trades at 15.9x Forward P/E, 16.2x Trailing P/E, 0.54x PEG, and 0.9x EV/Revenue (5.1% FCF margin), whereas LYB trades at 8.8x Forward P/E, 14.1x Trailing P/E, 0.85x PEG, and 0.9x EV/Revenue (7.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DOW (-3.2% ROE) versus LYB (12.2% ROE) capital efficiency.

In options market volatility and institutional positioning, DOW carries 40.2% implied volatility (20th %ile, Compressed (<25th %ile)), a 0.76x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.52β · 37% Vol realized risk). By comparison, LYB carries 39.2% implied volatility (38th %ile, Balanced (25th–60th %ile)), a 1.34x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.71β · 39% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.